Metformin works by decreasing glucose production and enhancing insulin sensitivity, which helps to lower insulin levels and blood sugar
prior utilization of incretin-based therapies within the preceding 12 months
In this analysis, a 68-week horizon was chosen to align with available data from the STEP-8 clinical trial [22]
When to adjust your plan Adjust your diet plan when you observe: Weight loss stalling for 3+ weeks despite consistent adherence (review calorie intake, consider a protocol adjustment ) Persistent fatigue beyond normal medication effects (likely under-eating or nutrient deficiency) Hair thinning or loss (protein deficiency, iron deficiency, or excessive caloric restriction) Strength declining in workouts (insufficient protein or calories to support recovery) GI symptoms not improving after 3-4 weeks at a stable dose (dietary triggers need identification) Use peptide calculators and tracking tools from SeekPeptides to monitor and adjust your protocol alongside your nutritional plan
If you experience hypoglycemia (low blood sugar levels), stop taking other glucose-lowering medications such as metformin and insulin glargine after consulting with your healthcare professional
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in GLP-1 receptor signaling (GLP1R rs6923761), GIPR signaling (GIPR rs1800437), and metabolic regulation (FTO rs9939609, MC4R rs17782313) to reveal predispositions in peptide genetic pathways
